Albumin News and Research

RSS

Baxter presents findings from the ADAPT study

Baxter Healthcare Corporation has announced the presentation of findings from the ADAPT (Analysis of Data from ADVATE Prospective Trials) study program database showing a statistically significant relationship between the duration of time spent with factor VIII blood levels below one international unit per deciliter (1 IU/dL, one percent of normal factor VIII level) and an increase in the annual bleed rate in people with hemophilia A.

11 Jul 2007

New drug-delivery system using nanomaterials

Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of today's most promising anticancer drugs and thereby increase their effectiveness.

8 Jun 2007

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

The researchers performed high resolution MRS on 15 amniotic fluid samples for evaluation of fetal lung maturity between 34 and 40 weeks gestation and were analyzed using trimethysilylpropionic acid (TSP) as a reference standard.

11 May 2007

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

8 May 2007

Twin studies identify genes that influence human health in unexpected ways

Daniel O'Connor, M.D., Professor of Medicine and Pharmacology at the University of California, San Diego (UCSD) School of Medicine has studied about 265 twin pairs over the past few years, which has led him to some surprising discoveries.

18 Apr 2007

Raman spectroscopy for faster body-fluid tests

University of Rochester researchers announce in the current issue of Applied Optics a technique that in 60 seconds or less measures multiple chemicals in body fluids, using a laser, white light, and a reflective tube.

4 Apr 2007

NAFLD fibrosis score helps predict advanced fibrosis in patients with nonalcoholic fatty liver disease

Certain routine demographic, clinical, and laboratory values can be used to identify advanced fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).

4 Apr 2007

Metabolic response to colitis varies depending upon whether inflammation is chronic or acute

A new study being published by the American Physiological Society finds that the body responds differently to colitis (inflammation of the colon) based on whether the disease is acute (sharp and brief) or chronic (long-term).

27 Feb 2007

Genetically engineered blood protein can be used to split water into oxygen and hydrogen

Scientists have combined two molecules that occur naturally in blood to engineer a molecular complex that uses solar energy to split water into hydrogen and oxygen, says research published in the Journal of the American Chemical Society.

2 Dec 2006

Study shows Diovan reduced urinary protein excretion in patients with type 2 diabetes and high blood pressure

In patients with high blood pressure and type 2 diabetes, the blood pressure-lowering medication Diovan (valsartan) significantly reduced urinary protein excretion, with high doses providing the greatest sustained reduction , according to data presented at the Amer ican Heart Association's (AHA) Annual Scientific Sessions.

13 Nov 2006

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.

5 Oct 2006

Key parameters for encapsulating drugs in nanoparticles

One of the early, successful uses of nanoparticles has been to develop delivery vehicles capable of ferrying large amounts of water-insoluble drugs to tumors.

2 Oct 2006

New developments in the technique of partial nephrectomy

While partial nephrectomy has demonstrated oncologic equipoise with radical nephrectomy, it remains a surgically daunting procedure that can be associated with significant complications, particularly related to hemostasis and prevention of post-operative urinary fistulae.

1 Sep 2006

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

25 Jul 2006

Herceptin-linked nanoparticles for targeted cancer therapy

Albumin nanoparticles have recently proven their mettle as anticancer agents with the 2005 approval of Abraxane to treat metastatic breast cancer.

17 Jul 2006

Yttrium-90 to control hepatocarcinoma

The University Hospital at the University of Navarra is the only centre throughout the entire Spanish state for the treatment of liver tumours by means of radioembolisation and the one with the greatest accumulated experiences in the treatment throughout Europe.

10 Jul 2006

Advancing nanoparticle-based imaging and therapy of brain cancer

Brain cancer is one of the most difficult malignancies to detect and treat, in large part because of the difficulty in getting imaging and therapeutic agents past the so-called blood-brain barrier and into the brain.

9 May 2006

Plain language labels now required for eight top allergens

If you or someone in your family suffers from a food allergy, you know how difficult it can be to decipher the food label if the product contains an offending substance.

20 Apr 2006

Study shows mercury amalgam fillings pose no health concerns for children

There were no statistically significant differences in neuropsychological and neurobehavioral effects among children whose dental caries were treated with mercury amalgam fillings and those treated with a composite dental restorative material

18 Apr 2006

Minimal nutritional requirements for growing and maintaining human embryonic stem cells

Researchers at Yale have established the minimal nutritional requirements for growing and maintaining human embryonic stem cells, a recipe that is critical for clinical application and for developmental studies, according to a report in the Proceedings of the National Academy of Sciences.

11 Apr 2006

Albumin News and Research

Baxter presents findings from the ADAPT study

New drug-delivery system using nanomaterials

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

MR spectroscopy of choline levels shows promise as a marker of fetal lung maturity

Twin studies identify genes that influence human health in unexpected ways

Raman spectroscopy for faster body-fluid tests

NAFLD fibrosis score helps predict advanced fibrosis in patients with nonalcoholic fatty liver disease

Metabolic response to colitis varies depending upon whether inflammation is chronic or acute

Genetically engineered blood protein can be used to split water into oxygen and hydrogen

Study shows Diovan reduced urinary protein excretion in patients with type 2 diabetes and high blood pressure

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

Key parameters for encapsulating drugs in nanoparticles

New developments in the technique of partial nephrectomy

Birch bark compound may be potent prostate cancer fighter

Herceptin-linked nanoparticles for targeted cancer therapy

Yttrium-90 to control hepatocarcinoma

Advancing nanoparticle-based imaging and therapy of brain cancer

Plain language labels now required for eight top allergens

Study shows mercury amalgam fillings pose no health concerns for children

Minimal nutritional requirements for growing and maintaining human embryonic stem cells

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News